ABCB6 and Alzheimer disease: The molecular mechanisms involved in the phenotype of AD following the functional barrier impairment in our material involve altered pathways such as cytoskeleton structure, calcium- and phospatidylinositol signaling and ATP binding cassette (ABC) transport system (Table 2).